Effectiveness of Iron oxide based Mandura Bhasma on Anemia.

A comparative pharmaceutico clinical study of Mandura Bhasma prepared by two different Bhavana dravya and their effect on Pandu Roga wsr to IRON DEFICIENCY ANEMIA - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/069930

Enrollment

Registered

2024-07-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified Health Condition 2: D509- Iron deficiency anemia, unspecified Health Condition 3: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age group between 18-60 years of both sexes. 2.Hemoglobin index(Hb gm/dl ranging =8g/dl - = 10gm/dl). 3.Selected patient sign and symptoms based as per both ayurvedic and modern context. 4.Willing to provide written consent.

Exclusion criteria

Exclusion criteria: 1.Age below 18 and above 60 years. 2.patient having bleeding history. 3.patient already on iron supplements 4.pregnant women ,co morbid patient and patient on prolonged medication

Design outcomes

Primary

Measure	Time frame
Evaluation of Hemoglobin level of patients before and after 112 days of treatmentTimepoint: 112 days	—

Secondary

Measure	Time frame
On baseline visit test for hemoglobin should be done along with genera examination then on every visit which is on 28 days of 1st then on 2nd & on 3rd visit the patient condition should be examined & on last visit which is 4th visit final hemoglobin estimation is done to know outcomeTimepoint: on every 28th days follow up should be done which is of 4 visit counted from baseline	—

Countries

India

Contacts

Public ContactDr Prabhat Kumar Dwivedi

GOVERNMENT AYURVEDIC COLLEGE AND HOSPITAL

drprabhatkd@gmail.com9431172175

Outcome results